CVE-2010-4895

Public Exploit

Description

Cross-site scripting (XSS) vulnerability in core/showsite.php in chillyCMS 1.1.3 allows remote attackers to inject arbitrary web script or HTML via the name parameter (aka the username field). NOTE: some of these details are obtained from third party information.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 7.80% Top 10%
Vendor Advisory secunia.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.bugreport.ir/index_73.htm
http://www.exploit-db.com/exploits/14897 exploit
http://securityreason.com/securityalert/8437 third party advisory
http://www.osvdb.org/67835 vdb entry
http://packetstormsecurity.org/1009-exploits/chillycms-sqlxss.txt
http://www.vupen.com/english/advisories/2010/2298 vdb entry
http://www.securityfocus.com/bid/42991 vdb entry
http://secunia.com/advisories/41313 third party advisory vendor advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/61607 vdb entry

Frequently Asked Questions

What is the severity of CVE-2010-4895?
CVE-2010-4895 has been scored as a medium severity vulnerability.
How to fix CVE-2010-4895?
To fix CVE-2010-4895, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-4895 being actively exploited in the wild?
It is possible that CVE-2010-4895 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~8% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.